The invention is directed to sublingual spray formulations containing sildenafil. The invention is further directed to methods of treating male sexual dysfunction or pulmonary arterial hypertension by administering sublingual spray formulations containing sildenafil to patients in need of such treatments. In one aspect, the present invention is directed to sublingual spray formulations comprising from about 0.1 % w/w to about 30% w/w of sildenafil.Linvention concerne des formulations de pulvérisation sublinguale contenant du sildénafil. Linvention concerne en outre des procédés de traitement dun dysfonctionnement sexuel masculin ou dune hypertension artérielle pulmonaire par administration de formulations de pulvérisation sublinguale contenant du sildénafil à des patients ayant besoin de tels traitements. Dans un aspect, la présente invention concerne des formulations de pulvérisation sublinguale comprenant denviron 0,1 % p/p à environ 30 % p/p de sildénafil.
